Cardiovascular Research 2015-05-01

In vivo assessment of cardiac metabolism and function in the abdominal aortic banding model of compensated cardiac hypertrophy.

Anne-Marie L Seymour, Lucia Giles, Vicky Ball, Jack J Miller, Kieran Clarke, Carolyn A Carr, Damian J Tyler

Index: Cardiovasc. Res. 106 , 249-60, (2015)

Full Text: HTML

Abstract

Left ventricular hypertrophy is an adaptive response of the heart to chronic mechanical overload and can lead to functional deterioration and heart failure. Changes in cardiac energy metabolism are considered as key to the hypertrophic remodelling process. The concurrence of obesity and hypertrophy has been associated with contractile dysfunction, and this work therefore aimed to investigate the in vivo structural, functional, and metabolic remodelling that occurs in the hypertrophied heart in the setting of a high-fat, high-sucrose, Western diet (WD).Following induction of cardiac hypertrophy through abdominal aortic banding, male Sprague Dawley rats were exposed to either a standard diet or a WD (containing 45% fat and 16% sucrose) for up to 14 weeks. Cardiac structural and functional characteristics were determined by CINE MRI, and in vivo metabolism was investigated using hyperpolarized (13)C-labelled pyruvate. Cardiac hypertrophy was observed at all time points, irrespective of dietary manipulation, with no evidence of cardiac dysfunction. Pyruvate dehydrogenase flux was unchanged in the hypertrophied animals at any time point, but increased incorporation of the (13)C label into lactate was observed by 9 weeks and maintained at 14 weeks, indicative of enhanced glycolysis.Hypertrophied hearts revealed little evidence of a switch towards increased glucose oxidation but rather an uncoupling of glycolytic metabolism from glucose oxidation. This was maintained under conditions of dietary stress provided by a WD but, at this compensated phase of hypertrophy, did not result in any contractile dysfunction.© The Author 2015. Published by Oxford University Press on behalf of the European Society of Cardiology.

Related Compounds

Structure Name/CAS No. Articles
Sodium hydroxide Structure Sodium hydroxide
CAS:1310-73-2
Pyruvic acid Structure Pyruvic acid
CAS:127-17-3
3-Ethyl-2,4-pentanedione Structure 3-Ethyl-2,4-pentanedione
CAS:1540-34-7
Ethylenediaminetetraacetic acid dipotassium salt dihydrate Structure Ethylenediaminetetraacetic acid dipotassium salt dihydrate
CAS:25102-12-9
acetic acid Structure acetic acid
CAS:1173022-32-6
acetic acid Structure acetic acid
CAS:64-19-7
Stanolone Structure Stanolone
CAS:521-18-6